$2.06
0.136.74%
Last update: Oct 2, 9:28 AM
$1.90
-0.03-1.55%
Vyome Holdings Inc (HIND) Stock Price, Quote, News & History
HINDNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vyome Holdings (NASDAQ:HIND) through any online brokerage.
Other companies in Vyome Holdings’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Vyome Holdings has a consensus price target of $9.25.
The stock price for Vyome Holdings (NASDAQ: HIND) is $1.9 last updated October 2, 2026 at 9:28 AM EDT.
There are no upcoming dividends for Vyome Holdings.
Vyome Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Vyome Holdings.
Vyome Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being...
